We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.22B
AUM Growth
+$186M
Cap. Flow
+$231M
Cap. Flow %
10.43%
Top 10 Hldgs %
42.94%
Holding
2,313
New
704
Increased
422
Reduced
406
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 6.33%
2 Healthcare 5.48%
3 Consumer Discretionary 4.35%
4 Industrials 3%
5 Real Estate 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUM
2126
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-3,865
Closed -$73K
RVNC
2127
DELISTED
Revance Therapeutics, Inc.
RVNC
-1,880
Closed -$24K
MRO
2128
DELISTED
Marathon Oil Corporation
MRO
-54,142
Closed -$769K
MRO
2129
PUT
DELISTED
Marathon Oil Corporation
MRO
-12,500
Closed -$178K
SAVE
2130
DELISTED
Spirit Airlines, Inc.
SAVE
-9,394
Closed -$395K
GVP
2131
DELISTED
GSE Systems, Inc.
GVP
-1,223
Closed -$29K
CHUY
2132
CALL
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
-8,900
Closed -$204K
CHUY
2133
PUT
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
-9,900
Closed -$227K
TUP
2134
DELISTED
Tupperware Brands Corporation
TUP
-458
Closed -$9K
LSXMA
2135
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
-6,022
Closed -$165K
SLCA
2136
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-1,500
Closed -$19K
CATC
2137
DELISTED
CAMBRIDGE BANCORP
CATC
-126
Closed -$10K
DCPH
2138
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-266
Closed -$6K
SCX
2139
DELISTED
The L.S. Starrett Company
SCX
-2,421
Closed -$16K
AMJ
2140
PUT
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
-1,800
Closed -$45K
DOOR
2141
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
-200
Closed -$11K
MRNS
2142
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-125
Closed -$2K
MRNS
2143
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-125
Closed -$2K
MRNS
2144
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-125
Closed -$2K
VIA
2145
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
-114
Closed -$6K
DSKE
2146
DELISTED
Daseke, Inc. Common Stock
DSKE
-9,674
Closed -$35K
CBAY
2147
DELISTED
Cymabay Therapeutics
CBAY
-767
Closed -$5K
AYX
2148
DELISTED
Alteryx Inc
AYX
-731
Closed -$80K
TGH
2149
DELISTED
Textainer Group Holdings limited
TGH
-810
Closed -$8K
LBC
2150
DELISTED
Luther Burbank Corporation Common Stock
LBC
-996
Closed -$11K

Similar funds

Prelude Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Prelude Capital Management held 2,313 positions worth $2.22B, up 9.1% from $2.03B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Prelude Capital Management deployed $231M of net new capital in Q3 2019, opening 704 new positions and adding to 422 existing holdings. Its largest new stake was Callon Petroleum Company: 418,579 shares worth $18.2M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Stewart Information Services, an estimated $7.45M trimmed.

  • Prelude Capital Management's largest Q3 2019 buy was Callon Petroleum Company: 418,579 shares worth $18.2M.
  • Prelude Capital Management added most to Altaba Inc in Q3 2019, an estimated $29.3M increase.
  • Prelude Capital Management's biggest Q3 2019 reduction was Stewart Information Services, cutting an estimated $7.45M.
  • Prelude Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $41.9M.
  • Prelude Capital Management's ten largest holdings make up 43% of its $2.22B portfolio in Q3 2019.
  • Prelude Capital Management opened 704 new positions and closed 646 in Q3 2019.
  • Prelude Capital Management's portfolio value rose 9.1% quarter-over-quarter to $2.22B.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.